Gabapentin and motor fluctuations in Parkinson's disease.
Identifieur interne : 004655 ( PubMed/Checkpoint ); précédent : 004654; suivant : 004656Gabapentin and motor fluctuations in Parkinson's disease.
Auteurs : P. Chaná [Chili] ; A. De Marinis ; N. BarrientosSource :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 1997.
English descriptors
- KwdEn :
- Acetates (therapeutic use), Aged, Amines, Antiparkinson Agents (therapeutic use), Cyclohexanecarboxylic Acids, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Motor Activity (drug effects), Movement Disorders (drug therapy), Parkinson Disease (drug therapy), Parkinson Disease (physiopathology), Treatment Outcome, gamma-Aminobutyric Acid.
- MESH :
- chemical , therapeutic use : Acetates, Antiparkinson Agents.
- drug effects : Motor Activity.
- drug therapy : Movement Disorders, Parkinson Disease.
- physiopathology : Parkinson Disease.
- Aged, Amines, Cyclohexanecarboxylic Acids, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Treatment Outcome, gamma-Aminobutyric Acid.
DOI: 10.1002/mds.870120421
PubMed: 9251083
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:9251083Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Gabapentin and motor fluctuations in Parkinson's disease.</title>
<author><name sortKey="Chana, P" sort="Chana, P" uniqKey="Chana P" first="P" last="Chaná">P. Chaná</name>
<affiliation wicri:level="1"><nlm:affiliation>Service of Neurology, Hospital DIPRECA, Santiago, Chile.</nlm:affiliation>
<country xml:lang="fr">Chili</country>
<wicri:regionArea>Service of Neurology, Hospital DIPRECA, Santiago</wicri:regionArea>
<wicri:noRegion>Santiago</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="De Marinis, A" sort="De Marinis, A" uniqKey="De Marinis A" first="A" last="De Marinis">A. De Marinis</name>
</author>
<author><name sortKey="Barrientos, N" sort="Barrientos, N" uniqKey="Barrientos N" first="N" last="Barrientos">N. Barrientos</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1997">1997</date>
<idno type="RBID">pubmed:9251083</idno>
<idno type="pmid">9251083</idno>
<idno type="doi">10.1002/mds.870120421</idno>
<idno type="wicri:Area/PubMed/Corpus">004629</idno>
<idno type="wicri:Area/PubMed/Curation">004629</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004655</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Gabapentin and motor fluctuations in Parkinson's disease.</title>
<author><name sortKey="Chana, P" sort="Chana, P" uniqKey="Chana P" first="P" last="Chaná">P. Chaná</name>
<affiliation wicri:level="1"><nlm:affiliation>Service of Neurology, Hospital DIPRECA, Santiago, Chile.</nlm:affiliation>
<country xml:lang="fr">Chili</country>
<wicri:regionArea>Service of Neurology, Hospital DIPRECA, Santiago</wicri:regionArea>
<wicri:noRegion>Santiago</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="De Marinis, A" sort="De Marinis, A" uniqKey="De Marinis A" first="A" last="De Marinis">A. De Marinis</name>
</author>
<author><name sortKey="Barrientos, N" sort="Barrientos, N" uniqKey="Barrientos N" first="N" last="Barrientos">N. Barrientos</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1997" type="published">1997</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acetates (therapeutic use)</term>
<term>Aged</term>
<term>Amines</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Cyclohexanecarboxylic Acids</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Motor Activity (drug effects)</term>
<term>Movement Disorders (drug therapy)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Treatment Outcome</term>
<term>gamma-Aminobutyric Acid</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Acetates</term>
<term>Antiparkinson Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Motor Activity</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Movement Disorders</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Amines</term>
<term>Cyclohexanecarboxylic Acids</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Treatment Outcome</term>
<term>gamma-Aminobutyric Acid</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">9251083</PMID>
<DateCreated><Year>1997</Year>
<Month>10</Month>
<Day>14</Day>
</DateCreated>
<DateCompleted><Year>1997</Year>
<Month>10</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>06</Month>
<Day>11</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN>
<JournalIssue CitedMedium="Print"><Volume>12</Volume>
<Issue>4</Issue>
<PubDate><Year>1997</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Gabapentin and motor fluctuations in Parkinson's disease.</ArticleTitle>
<Pagination><MedlinePgn>608</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chaná</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Service of Neurology, Hospital DIPRECA, Santiago, Chile.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>de Marinis</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Barrientos</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>UNITED STATES</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000085">Acetates</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000588">Amines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003509">Cyclohexanecarboxylic Acids</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>56-12-2</RegistryNumber>
<NameOfSubstance UI="D005680">gamma-Aminobutyric Acid</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>6CW7F3G59X</RegistryNumber>
<NameOfSubstance UI="C040029">gabapentin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000085">Acetates</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y" UI="D000588">Amines</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000978">Antiparkinson Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y" UI="D003509">Cyclohexanecarboxylic Acids</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004359">Drug Therapy, Combination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009043">Motor Activity</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009069">Movement Disorders</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y" UI="D005680">gamma-Aminobutyric Acid</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1997</Year>
<Month>7</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1997</Year>
<Month>7</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1997</Year>
<Month>7</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">9251083</ArticleId>
<ArticleId IdType="doi">10.1002/mds.870120421</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Chili</li>
</country>
</list>
<tree><noCountry><name sortKey="Barrientos, N" sort="Barrientos, N" uniqKey="Barrientos N" first="N" last="Barrientos">N. Barrientos</name>
<name sortKey="De Marinis, A" sort="De Marinis, A" uniqKey="De Marinis A" first="A" last="De Marinis">A. De Marinis</name>
</noCountry>
<country name="Chili"><noRegion><name sortKey="Chana, P" sort="Chana, P" uniqKey="Chana P" first="P" last="Chaná">P. Chaná</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004655 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 004655 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:9251083 |texte= Gabapentin and motor fluctuations in Parkinson's disease. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:9251083" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
This area was generated with Dilib version V0.6.23. |